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302Objectives:Management of pacemaker infection in pacing-dependent patients is often challenging. Typically,
temporary pacing is used while antibiotic therapy is given for a number of days before reimplantation of a new
endocardial system. This results in a prolonged hospital stay and complications associated with temporary pac-
ing. In this study, we examine the feasibility of performing a single combined procedure of epicardial pacemaker
implantation followed by system extraction.
Methods:One hundred consecutive infected pacemaker-dependent patients underwent implantation of 2 epicar-
dial ventricular leads and were converted to a ventricular demand pacing system. The infected pacing system
was then extracted during the same procedure. Patients were followed up for 12 months.
Results: Significant pericardial bleeding developed during the procedure in 3 patients. The presence of the peri-
cardial drain positioned during the implantation of the epicardial pacing system meant that cardiac tamponade
did not occur, allowing surgical repair with sternotomy to be carried out under stable hemodynamic conditions.
Two of these 100 patients died in the 30-day postoperative period; 1 death was due to septic shock and 1 to pul-
monary distress. Median 1-year epicardial pacing thresholds were stable and excellent (1.4  0.9 volts). How-
ever, 1 of the 2 leads developed increased thresholds in 6 patients, which led to the exclusive use of other
ventricular lead.
Conclusions: A single combined procedure of surgical epicardial pacemaker implantation and pacemaker
system extraction appears to be a safe and effective method for managing pacemaker-dependent patients
with infected pacemakers. (J Thorac Cardiovasc Surg 2013;146:302-5)Management of patients with pacemaker infections can be
challenging. Guidelines on management of endocarditis
have been published with specific reference to infections
of implanted devices; however, little published data exist
and there is no firm consensus about the best approach for
reimplantation after pacemaker extraction.1
There are 2 class I indications on this specific subject: (1)
After removal of the infected device, each patient should be
carefully evaluated to determine whether there is a contin-
ued need for pacing therapy. In pacemaker-dependent pa-
tients, there is obviously an absolute need for ensuring
continuity of pacing. (2) The replacement device should
not be implanted on the same side as the device that re-
quired extraction. Alternative locations include therdeaux University 2 and University Medical Center of Bordeaux, Bordeaux,
e.
res: Authors have nothing to disclose with regard to commercial support.
d for publication April 23, 2012; revisions received July 9, 2012; accepted for
ation July 23, 2012; available ahead of print Sept 10, 2012.
for reprints: Pierre Bordachar, MD, Hospital Haut Leveque, Service Pr. Hais-
rre, Pessac 33604, France (E-mail: bordacharp@hotmail.com).
23/$36.00
ht  2013 by The American Association for Thoracic Surgery
.doi.org/10.1016/j.jtcvs.2012.07.026
The Journal of Thoracic and Cardiovascular Surgcontralateral subclavian vein, the iliac vein, or a surgical
epicardial approach. The selected approach depends on
the individual patient characteristics and preferences of
individual centres.2-4 To try to minimize the risk of
infection of the new device developing, many centers give
a prolonged course of antibiotic therapy after removal of
the infected system before reimplantation. Practice varies
regarding the duration of antibiotic therapy given before
reimplantation of the new pacemaker system. Some
centers give at least 14 days of antibiotic therapy after
extraction before reimplantation.1 In pacing-dependent pa-
tients, it is of course necessary to provide temporary pacing
during this time; commonly, this is performed with a tempo-
rary pacing wire. Temporary pacing has a number of poten-
tial drawbacks. Patients find it uncomfortable, the pacing
wire is susceptible to becoming displaced, and as a result,
patients are often immobilized. Typically, the pacing wire
is changed at regular intervals to minimize the risk of infec-
tion. Implantation of traditional pacing leads connected to
an external pacemaker has been proposed in some centers
to reduce the risk of dislodgment.
In this study we investigate the feasibility and safety of
a single combined procedure to manage pacemaker-
dependent patients with pacemaker infection. The potentialery c August 2013
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Dadvantages of this approach are that it may reduce the length
of hospital stay and allow patients to recover more rapidly;
furthermore, it is not associated with the disadvantages of
prolonged treatment with temporary pacing. After initiation
of antibiotic therapy, we implanted an epicardial pacemaker
via a subxiphoid approach. By implanting the system ex-
travascularly, we hypothesized that this would minimize
the risk of reinfection of the device and therefore allow us
to implant the device immediately before extraction of the
infected endocardial device, which was all performed dur-
ing the same surgical procedure. We systematically im-
planted 2 ventricular leads connected to a dual-chamber
pacemaker to provide backup pacing in case of a threshold
rise on 1 of the ventricular leads.METHODS
Our center is a regional referral center for investigation and treatment of
patients with device infection. We serve a large area of southwest France,
receiving referrals from many medium-sized and smaller hospitals. In this
geographic area, 3544  126 pacemakers were implanted per year in the
past 5 years. Between 2008 and 2010, a total of 100 pacing-dependent pa-
tients were referred to our center for extraction of an infected pacemaker.
Patients were considered to be pacing dependent as a result of complete
heart block if (1) interrogation of the pacemaker the day before extraction
demonstrated more than 95% right ventricular pacing and (2) an electro-
cardiogram demonstrated complete atrioventricular block.
Diagnosis of Device Infection
Patients with a clinical suspicion of device infections underwent a stan-
dardized clinical care pathway at our center. This included a detailed his-
tory, clinical examination, routine blood tests including inflammatory
markers, wound swabs, and multiple blood cultures (minimum of 3 sets).
All patients had both transthoracic and transesophageal echocardiography
performed. Images were reviewed independently by 2 specialists, with veg-
etations defined as an oscillating intracardiac mass on the leads, cardiac
valve leaflets, or endocardial surface. A diagnosis of local infection was
made when the clinical manifestations were limited to signs of pocket in-
fection.4-6 A diagnosis of lead endocarditis was made according to the
modified Duke criteria, as previously published.1,2,7
Antibiotic Therapy
All patients were treated with antibiotics before the surgical procedure.
Antibiotics were commenced 2 days before the procedure. The antibiotic
regimen was adjusted according to microbiology results and was guided
by an infectious disease specialist. Vancomycin was used as first-line em-
pirical therapy until the culprit pathogen was identified.8,9
Surgical Procedure
The procedure was performed in an operating room under aseptic con-
ditions and with general anesthesia. The surgical technique was the same
for all patients, irrespective of their initial clinical presentation.
Implantation of the new device. A subxiphoid incision was per-
formed and the right ventricle was exposed. Two bipolar, steroid-eluting
epicardial leads (Medtronic 4968 lead [Medtronic, Inc, Minneapolis,
Minn] or St Jude Medical 1084T lead [St Jude Medical, Inc, St Paul,
Minn]) were secured to the posterolateral wall of the right ventricle in a po-
sition where sensing, pacing, and impedance measurements were
satisfactory.
The pacemaker was programmed before lead connection in DDIR
mode. The sensing and pacing configurations were programmed to bipolar.The Journal of Thoracic and Ca‘‘Atrial’’ sensitivity (the second ventricular lead was connected to the atrial
port) was set at 2.5 mV. The atrioventricular paced and sensed atrioventric-
ular delays were set to the minimal value (usually 30 ms).
The 2 ventricular leads were connected to the generator, 1 to the atrial
port and the other to the ventricular port. The generator was placed in
the right upper quadrant of the abdominal wall via the subxiphoid incision.
A pericardial drain was left in place; the wound was closed and covered.
Extraction of the infected pacing system. In all patients, the
leads were extracted via a transvenous approach. The transvenous lead ex-
tractions were performed by a cardiologist and cardiovascular surgeons ex-
perienced in lead extraction procedures. When extracting from the
subclavian approach, we used a combination of simple traction, mechani-
cal dilator sheaths, or a laser sheath (CVX-300 Excimer laser system; Spec-
tranetics Co, Colorado Springs, Colo) as required. When extracting from
the femoral approach, we used a Dotter helical basket (CookVascular, Van-
dergrift, Pa) or a Needle’s Eye Snare (Cook Vascular).10-12 All pacemaker
material was sent for culture.
Complete extraction was defined as the removal of the entire lead and
partial extraction as the removal of most of the lead components, except
for the electrode tip or less than 2.0 cm of wire or insulation. Procedures
were classified as unsuccessful when these end points were not reached.1
End Points and Follow-up
The 3 main end points of the study were the safety of the procedure, re-
currence of infection, and pacing system failure. All patients underwent
routine device follow-up at 1, 6, and 12 months with special attention
paid to signs of local and general infection, signs of bradycardia (dizzy
spells, syncope, or presyncope), and analysis of the lead performance.
Statistical Analysis
The data are presented as means  standard deviation. Short-term and
long-term pacing thresholds were compared by the 2-tailed paired Student
t test. All statistical analyses were performed using the SPSS software,
version 17.0 (SPSS Inc, Chicago, Ill).RESULTS
Patients
Table 1 shows selected baseline characteristics of the 100
patients enrolled in the present study.Surgical Procedure
Implantation of the new device. The pacemaker was im-
planted successfully in all patients. We did not observe any
complication during the implantation procedure. The mean
ventricular pacing threshold was 1.1  0.5 volts at a pulse
width of 0.5 ms. No short-term pacing threshold was greater
than 3.5 volts at 0.5 ms.
Extraction of the infected pacemaker. Complete extrac-
tion was achieved in 95 (95%) patients and incomplete ex-
traction in the other 5 (5%) (the tip of the lead remained in
situ). A pericardial effusion developed in 3 patients. The
presence of the pericardial drain, inserted during the im-
plantation of the epicardial pacing system, prevented peri-
cardial tamponade. Surgical repair was required in 2
patients; a median sternotomy was performed promptly un-
der stable hemodynamic conditions (1 myocardial tear at
the right ventricular level and 1 at the atrial level). No intra-
procedural deaths occurred.rdiovascular Surgery c Volume 146, Number 2 303
TABLE 1. Baseline characteristics of the 100 patients
Age, y 73  14
Women (%) 21.0
Atrial fibrilation (%) 11.0
Sinus rhythm (%) 89.0
Local infection (%) 47.0
Lead endocarditis (%) 53.0
No. of lead 2.1  0.4
Mean age of the extracted leads, mo 123.0  76.8
Cardiomyopathy (%)
Ischemic 22.0
Valvular 11.0
Other 16.0
No cardiomyopathy (%) 54.0
Ejection fraction (%) 54.6  11.3
Organisms (%)
Staphylococcus aureus 16.0
Staphylococcus epidermidis 32.0
Staphylococcus capitis 6.0
Staphylococcus schleferi 4.0
Other staphylococcus 7.0
Nonstaphylococcus 12.0
Nondocumented 23.0
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The mean stay in the high dependency postoperative
ward was 1.3  0.8 days. One patient had a small subcuta-
neous hematoma in the epigastric area; this did not require
any further action. Two patients needed prolonged ventila-
tory support for postoperative atelectasis. In all the other pa-
tients the drain was removed and patients were able to
mobilize the day after the operation. Two (2%) in-
hospital deaths occurred; 1 was due to septic shock and oc-
curred 1 day after the operation, and the other was due to
pulmonary distress and occurred at day 7. In these 2 patients
we did not observe any signs of early abdominal wound in-
fection. The septic shock is likely to have been favored by
the procedure of extraction with dissemination of the germs
at this time.
Long-Term Follow-up
One-year mortality was 4%: the 2 in-hospital deaths, 1
death owing to progressive right ventricular dysfunction re-
lated to a tricuspid vegetation and resultant regurgitation,
and 1 owing to pulmonary insufficiency. One patient had
an incisional hernia of the subxiphoid wound that required
surgical repair. This complication was thought to be due to
progressive motion of the pacing device inside the pocket,
and there were no clinical and or biological manifestations
of primary pocket infection. We did not observe other pa-
tients with late wound infection.
The mean ventricular pacing thresholds at 12 months’
follow-up was 1.4 0.9 volts at 0.5 ms (P¼ .04 vs postim-
plant thresholds) and in the majority of patients pacing
thresholds were stable. However, we observed an increase304 The Journal of Thoracic and Cardiovascular Surgin pacing thresholds (>3.5 volts at 0.5 ms) in 1 of the leads
in 6 patients. This did not result in clinical manifestations in
any of the patients, because pacing threshold remained sat-
isfactory in the other lead. Reintervention was not required
in any patients inasmuch as pacing was successfully deliv-
ered via the other ventricular lead.
DISCUSSION
In this study we show that a single combined surgical pro-
cedure—implantation of an epicardial pacemaker followed
by extraction of the infected pacemaker—is a feasible and
safe method for managing pacemaker-dependent patients
with pacemaker infection.
The advantages of a single combined procedure include
the following: (1) First, the risk of asystole is reduced owing
to loss of pacing as a result of displacement of the temporary
pacing wire. In the mid term, we found that the epicardial
pacing system was reliable with stable thresholds in the ma-
jority of patients. Implanting 2 ventricular leads provided
backup pacing in case of a threshold rise on 1 of the ventric-
ular leads (6% of patients). (2) The other risks associated
with temporary pacing are also eliminated; for example,
the risk of pericardial tamponade during repeated place-
ments of the pacing wire as well as the risk for infection
of the temporary pacing wire, either because it comes into
contact with the original infected material or owing to de
novo infections, are eliminated. (3) Infection risk of epicar-
idal devices may be lower than in endovascular devices be-
cause the implanted system (pacemaker plus leads) is
totally extravascular. Importantly, after 12 months’
follow-up we did not observe any infections of the newly
implanted epicardial device, despite implantation occurring
immediately before extraction of the infected pacemaker.
(4) The single combined surgical procedure may also re-
duce the operative risks associated with the extraction pro-
cedure. In the present study, we observed a complication
rate comparable with previously published data.1-5,13,14
The presence of the pericardial drain inserted as part of
the epicardial pacemaker implantation has been a helpful
safety feature; bleeding into the drain allows early
diagnosis of pericardial myocardial damage to be made.
Therefore, surgical repair can be performed promptly and
cardiac tamponade is prevented, allowing emergency
repair to be done in good hemodynamic conditions. (5)
Finally, the combined surgical approach should result in
shorter duration of hospitalization compared with the
currently widely used 2-stage approach.
In contrast, the disadvantages of the single surgical pro-
cedure include the following: (1) The presence of previous
thoracic or cardiac surgery may increase the complexity of
the epicardial implantation procedure. A potential interest-
ing alternative surgical approach may be to propose a left
anterior thoracotomy. (2) Pacing in VVI mode elicits
a loss of atrioventricular synchrony and potential for theery c August 2013
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proach we used in this study did not lend itself well to the
implantation of an atrial lead. However, in our population,
the vast majority did not have retrograde ventriculoatrial
conduction and we did not observe cases of pacemaker syn-
drome. However, we recognize that in certain patients
maintenance of atrioventricular synchrony is important
and therefore refinement of the surgical technique may be
required, particularly in young patients in whom the loss
of atrioventricular synchrony may not be acceptable in the
long term. One alternative approach is the minimally inva-
sive robotically assessed approach. We now routinely use
this approach at our institution for implantation of dual
chamber in young patients. The implantation of an atrioven-
tricular system is feasible with 1 left atrial lead and 2 left
ventricular leads connected to a cardiac resynchronization
pacing device.15 (3) We systematically implanted a dual-
chamber device with an extra cost compared with a sin-
gle-chamber device. However, we consider that it increases
the safety in these pacemaker-dependent patients and may
be cost effective inasmuch as it may reduce the incidence
of the need for reintervention.
Limitations
This study is observational and no direct comparison with
another strategy was performed. Therefore, all the points
discussed in this article in terms of advantages or disadvan-
tages compared with the traditional strategy are assump-
tions. Adequately powered prospective controlled studies
would be required to confirm these assumptions.
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